Nuveen Asset Management’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $6.95M | Sell |
125,539
-15,186
| -11% | -$841K | ﹤0.01% | 1807 |
|
|
2024
Q3 | $4.63M | Sell |
140,725
-244,360
| -63% | -$8.04M | ﹤0.01% | 2026 |
|
|
2024
Q2 | $10.5M | Buy |
385,085
+228,298
| +146% | +$6.21M | ﹤0.01% | 1552 |
|
|
2024
Q1 | $5.7M | Sell |
156,787
-79,655
| -34% | -$2.9M | ﹤0.01% | 1922 |
|
|
2023
Q4 | $4.79M | Buy |
236,442
+130,841
| +124% | +$2.65M | ﹤0.01% | 2006 |
|
|
2023
Q3 | $1.88M | Buy |
105,601
+36,139
| +52% | +$642K | ﹤0.01% | 2323 |
|
|
2023
Q2 | $1.26M | Buy |
69,462
+25,582
| +58% | +$462K | ﹤0.01% | 2547 |
|
|
2023
Q1 | $552K | Sell |
43,880
-5,185
| -11% | -$65.2K | ﹤0.01% | 2788 |
|
|
2022
Q4 | $719K | Sell |
49,065
-7,953
| -14% | -$117K | ﹤0.01% | 2800 |
|
|
2022
Q3 | $976K | Sell |
57,018
-2,052
| -3% | -$35.1K | ﹤0.01% | 2765 |
|
|
2022
Q2 | $862K | Buy |
59,070
+37,307
| +171% | +$544K | ﹤0.01% | 2854 |
|
|
2022
Q1 | $381K | Hold |
21,763
| – | – | ﹤0.01% | 3076 |
|
|
2021
Q4 | $565K | Hold |
21,763
| – | – | ﹤0.01% | 3045 |
|
|
2021
Q3 | $496K | Sell |
21,763
-3,960
| -15% | -$90.3K | ﹤0.01% | 3168 |
|
|
2021
Q2 | $745K | Buy |
25,723
+10,891
| +73% | +$315K | ﹤0.01% | 3099 |
|
|
2021
Q1 | $478K | Buy |
14,832
+4,744
| +47% | +$153K | ﹤0.01% | 3106 |
|
|
2020
Q4 | $417K | Buy |
+10,088
| New | +$417K | ﹤0.01% | 3079 |
|